BIOMAT Database Logo BIOMAT Database Logo

Progestogen-only oral contraceptives and risk of breast cancer in New Zealand. 1996

D C Skegg, and C Paul, and G F Spears, and S M Williams
Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.

Little is known about the influence of progestogen-only oral contraceptives on a woman's risk of breast cancer. This issue was examined in a national population-based case-control study in New Zealand. A total of 891 women aged 25 to 54 years with a first diagnosis of breast cancer and 1,864 control subjects, randomly selected from the electoral rolls, were interviewed. Use of progestogen-only pills was reported by 8.7 percent of all control subjects (and by 17.3 percent of those aged 25 to 34 years). The relative risk (RR) of breast cancer in women who had ever used progestogen-only pills was estimated to be 1.1 (95 percent confidence interval [CI] = 0.73-1.5). In women aged 25 to 34 years, the RR was 2.3 (CI = 1.2-4.3). Women who had started using progestogen-only pills within the last 10 years were at increased risk of breast cancer (RR = 1.6, CI = 1.0-2.4), whereas those who had first used them earlier were at significantly reduced risk (RR = 0.44, CI = 0.22-0.90). These findings are similar to results for depot medroxyprogesterone acetate, and a possible analogy with the influence of pregnancy is also suggested.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009520 New Zealand A group of islands in the southwest Pacific. Its capital is Wellington. It was discovered by the Dutch explorer Abel Tasman in 1642 and circumnavigated by Cook in 1769. Colonized in 1840 by the New Zealand Company, it became a British crown colony in 1840 until 1907 when colonial status was terminated. New Zealand is a partly anglicized form of the original Dutch name Nieuw Zeeland, new sea land, possibly with reference to the Dutch province of Zeeland. (From Webster's New Geographical Dictionary, 1988, p842 & Room, Brewer's Dictionary of Names, 1992, p378)
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011372 Progestins Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. Gestagenic Agent,Progestagen,Progestagenic Agent,Progestational Agent,Progestational Compound,Progestational Hormone,Progestogen,Progestogens,Gestagen,Gestagen Effect,Gestagen Effects,Gestagenic Agents,Gestagenic Effect,Gestagenic Effects,Gestagens,Progestagenic Agents,Progestagens,Progestational Agents,Progestational Compounds,Progestational Hormones,Progestin,Progestin Effect,Progestin Effects,Progestogen Effect,Progestogen Effects,Agent, Gestagenic,Agent, Progestagenic,Agent, Progestational,Compound, Progestational,Effect, Gestagen,Effect, Gestagenic,Effect, Progestin,Effect, Progestogen,Effects, Gestagen,Effects, Gestagenic,Effects, Progestin,Effects, Progestogen,Hormone, Progestational
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003278 Contraceptives, Oral, Hormonal Oral contraceptives which owe their effectiveness to hormonal preparations. Hormonal Oral Contraceptive,Hormonal Oral Contraceptive Agent,Contraceptive Agents, Estrogen,Contraceptive Agents, Oral, Hormonal,Hormonal Oral Contraceptive Agents,Oral Contraceptive Agents, Hormonal,Oral Contraceptives, Hormonal,Contraceptive, Hormonal Oral,Contraceptives, Hormonal Oral,Estrogen Contraceptive Agents,Hormonal Oral Contraceptives,Oral Contraceptive, Hormonal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D C Skegg, and C Paul, and G F Spears, and S M Williams
Progestogen-only contraceptives and cancer risk.
April 2002, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
D C Skegg, and C Paul, and G F Spears, and S M Williams
Progestogen-only oral contraceptives.
August 1969, British medical journal,
D C Skegg, and C Paul, and G F Spears, and S M Williams
Progestogen-only oral contraceptives.
April 2022, Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia,
D C Skegg, and C Paul, and G F Spears, and S M Williams
Plasma lipids in women using progestogen-only oral contraceptives.
June 1983, British journal of obstetrics and gynaecology,
D C Skegg, and C Paul, and G F Spears, and S M Williams
Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives.
February 2000, American journal of epidemiology,
D C Skegg, and C Paul, and G F Spears, and S M Williams
Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
June 1999, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception,
D C Skegg, and C Paul, and G F Spears, and S M Williams
Effects of progestogen-only contraceptives on breast-feeding and infant growth.
August 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
D C Skegg, and C Paul, and G F Spears, and S M Williams
Oral contraceptives and breast cancer risk.
November 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
D C Skegg, and C Paul, and G F Spears, and S M Williams
Oral contraceptives and breast cancer risk.
March 1997, Advances in contraception : the official journal of the Society for the Advancement of Contraception,
D C Skegg, and C Paul, and G F Spears, and S M Williams
Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer.
November 2018, The Linacre quarterly,
Copied contents to your clipboard!